Combined pulmonary fibrosis and emphysema syndrome

Pneumon

Volumn 22, Issue 2, 2009, Pages 128-130

  Bouros, Demosthenes ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; PLATELET DERIVED GROWTH FACTOR B; TUMOR NECROSIS FACTOR ALPHA;

BRONCHIECTASIS; COMBINED PULMONARY FIBROSIS AND EMPHYSEMA SYNDROME; DIFFERENTIAL DIAGNOSIS; DYSPNEA; EDITORIAL; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPOXEMIA; LUNG DISEASE; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VOLUME; MORTALITY; NONHUMAN; OXYGEN SATURATION; OXYGEN TENSION; PROGNOSIS; PULMONARY HYPERTENSION; RESPIRATORY AIRFLOW; SEX DIFFERENCE; SMOKING CESSATION; SMOKING HABIT; SURVIVAL TIME; THORAX RADIOGRAPHY;

EID: 77953410598     PISSN: 1105848X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. Karakatsani A, Papakosta D, Rapti A, et al. Epidemiology of interstitial lung diseases in Greece. Respir Med. 2009 Apr 2. [Epub ahead of print]
2. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 1990; 84: 365-9
3. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26: 586-93
4. Mejia M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136 (in press).
5. Bouros D. The new ATS/ERS/JRS IPF Guidelines.Pneumon 2008;21:117-121.
6. Lundblad LK, Thompson-Figueroa J, Leclair T, et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med. 2005;171:1363-70.
7. Hoyle GW, Li J, Finkelstein JB, Eisenberg T, et al. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol. 1999;154:1763-75.
8. Rogliani P, Mura M, Mattia P, et al. HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med. 2008;102:1753-61.